相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Long-term efficacy and safety of eladocagene exuparvovec in patients with AADC deficiency
Chun-Hwei Tai et al.
MOLECULAR THERAPY (2022)
AAV gene therapy for Tay-Sachs disease
Terence R. Flotte et al.
NATURE MEDICINE (2022)
Disruptions in the development of cell and gene therapies
Guang Yang et al.
NATURE REVIEWS DRUG DISCOVERY (2022)
Safety of AADC Gene Therapy for Moderately Advanced Parkinson Disease Three-Year Outcomes From the PD-1101 Trial
Chadwick W. Christine et al.
NEUROLOGY (2022)
Gene Therapy Advances: A Meta-Analysis of AAV Usage in Clinical Settings
Hau Kiu Edna Au et al.
FRONTIERS IN MEDICINE (2022)
Gene Therapy for Neurological Disease: State of the Art and Opportunities for Next-generation Approaches
Gareth Morris et al.
NEUROSCIENCE (2022)
Considerations for the chemistry, manufacturing and Controls (CMC)-quality package for COVID-19 vaccines- interim lessons learnt by the European medicines Agency (EMA)
Ragini Shivji et al.
VACCINE (2022)
Optimization of adeno-associated viral vector-mediated transduction of the corticospinal tract: comparison of four promoters
Bart Nieuwenhuis et al.
GENE THERAPY (2021)
Deep diversification of an AAV capsid protein by machine learning
Drew H. Bryant et al.
NATURE BIOTECHNOLOGY (2021)
Gene-based therapies for neurodegenerative diseases
Jichao Sun et al.
NATURE NEUROSCIENCE (2021)
Engineered microRNA-based regulatory element permits safe high-dose miniMECP2 gene therapy in Rett mice
Sarah E. Sinnett et al.
BRAIN (2021)
Overcoming Immunological Challenges Limiting Capsid-Mediated Gene Therapy With Machine Learning
Anna Z. Wec et al.
FRONTIERS IN IMMUNOLOGY (2021)
AAV manufacturing for clinical use: Insights on current challenges from the upstream process
Terrence Dobrowsky et al.
CURRENT OPINION IN BIOMEDICAL ENGINEERING (2021)
Regulators' Advice Can Make a Difference: European Medicines Agency Approval of Zynteglo for Beta Thalassemia
Martina Schuessler-Lenz et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2020)
AAV Vector Immunogenicity in Humans: A Long Journey to Successful Gene Transfer
Helena Costa Verdera et al.
MOLECULAR THERAPY (2020)
Slowing late infantile Batten disease by direct brain parenchymal administration of a rh.10 adeno-associated virus expressing CLN2
Dolan Sondhi et al.
SCIENCE TRANSLATIONAL MEDICINE (2020)
The once and future gene therapy
Karen Bulaklak et al.
NATURE COMMUNICATIONS (2020)
Voretigene Neparvovec in Retinal Diseases: A Review of the Current Clinical Evidence
Jie Gao et al.
CLINICAL OPHTHALMOLOGY (2020)
Establishing a reasonable price for an orphan drug
Mikel Berdud et al.
COST EFFECTIVENESS AND RESOURCE ALLOCATION (2020)
Magnetic resonance imaging-guided phase 1 trial of putaminal AADC gene therapy for Parkinson's disease
Chadwick W. Christine et al.
ANNALS OF NEUROLOGY (2019)
Global, regional, and national burden of neurological disorders, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016
Valery L. Feigin et al.
LANCET NEUROLOGY (2019)
Therapeutic landscape for Batten disease: current treatments and future prospects
Tyler B. Johnson et al.
NATURE REVIEWS NEUROLOGY (2019)
Cholesterol 24-Hydroxylation by CYP46A1: Benefits of Modulation for Brain Diseases
Alexey M. Petrov et al.
NEUROTHERAPEUTICS (2019)
Recombinant Adeno-Associated Virus Gene Therapy in Light of Luxturna (and Zolgensma and Glybera): Where Are We, and How Did We Get Here?
Allison M. Keeler et al.
ANNUAL REVIEW OF VIROLOGY, VOL 6, 2019 (2019)
Comprehensive AAV capsid fitness landscape reveals a viral gene and enables machine-guided design
Pierce J. Ogden et al.
SCIENCE (2019)
The Extended Treatment Window's Impact on Emergency Systems of Care for Acute Stroke
Joseph B. Miller et al.
ACADEMIC EMERGENCY MEDICINE (2019)
Gene Therapy for Neurodegenerative Diseases
Vivek Sudhakar et al.
NEUROTHERAPEUTICS (2019)
A systematic capsid evolution approach performed in vivo for the design of AAV vectors with tailored properties and tropism
Marcus Davidsson et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2019)
Synthetic Adeno-Associated Viral Vector Efficiently Targets Mouse and Nonhuman Primate Retina In Vivo
Livia S. Carvalho et al.
HUMAN GENE THERAPY (2018)
Gene Therapy for Parkinson's Disease, An Update
Tobias M. Axelsen et al.
JOURNAL OF PARKINSONS DISEASE (2018)
Gene therapy for neurological disorders: progress and prospects
Benjamin E. Deverman et al.
NATURE REVIEWS DRUG DISCOVERY (2018)
Long-Term Follow-Up of a Phase I/II Study of ProSavin, a Lentiviral Vector Gene Therapy for Parkinson's Disease
Stephane Palfi et al.
HUMAN GENE THERAPY CLINICAL DEVELOPMENT (2018)
Efficient Gene Transfer to the Central Nervous System by Single-Stranded Anc80L65
Eloise Hudry et al.
MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT (2018)
Adeno-associated virus (AAV) vectors: Rational design strategies for capsid engineering
Esther J. Lee et al.
CURRENT OPINION IN BIOMEDICAL ENGINEERING (2018)
After Glybera's withdrawal, what's next for gene therapy?
Melanie Senior
NATURE BIOTECHNOLOGY (2017)
Hematopoietic Stem-Cell Gene Therapy for Cerebral Adrenoleukodystrophy
Florian Eichler et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
The path to successful commercialization of cell and gene therapies: empowering patient advocates
Gerhard Bauer et al.
CYTOTHERAPY (2017)
Promoter methylation and histone modifications affect the expression of the exogenous DsRed gene in transgenic goats
M. T. Nuo et al.
GENETICS AND MOLECULAR RESEARCH (2016)
AAV gene transfer delays disease onset in a TPP1-deficient canine model of the late infantile form of Batten disease
Martin L. Katz et al.
SCIENCE TRANSLATIONAL MEDICINE (2015)
Enzyme replacement in the CSF to treat metachromatic leukodystrophy in mouse model using single intracerebroventricular injection of self-complementary AAV1 vector
Kohei Hironaka et al.
SCIENTIFIC REPORTS (2015)
In Silico Reconstruction of the Viral Evolutionary Lineage Yields a Potent Gene Therapy Vector
Eric Zinn et al.
CELL REPORTS (2015)
Re-examination of regulatory opinions in Europe: possible contribution for the approval of the first gene therapy product Glybera
Natsumi Watanabe et al.
MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT (2015)
Intracerebral Administration of Adeno-Associated Viral Vector Serotype rh.10 Carrying Human SGSH and SUMF1 cDNAs in Children with Mucopolysaccharidosis Type IIIA Disease: Results of a Phase I/II Trial
Marc Tardieu et al.
HUMAN GENE THERAPY (2014)
Whole body correction of mucopolysaccharidosis IIIA by intracerebrospinal fluid gene therapy
Virginia Haurigot et al.
JOURNAL OF CLINICAL INVESTIGATION (2013)
Breathing challenges in Rett Syndrome: Lessons learned from humans and animal models
Jan-Marino Ramirez et al.
RESPIRATORY PHYSIOLOGY & NEUROBIOLOGY (2013)
Targeted methylation of CMV and E1A viral promoters
Chia-Chen Hsu et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2010)
A Phase I Study of Aromatic L-Amino Acid Decarboxylase Gene Therapy for Parkinson's Disease
Shin-ichi Muramatsu et al.
MOLECULAR THERAPY (2010)
Safety and tolerability of putaminal AADC gene therapy for Parkinson disease
C. W. Christine et al.
NEUROLOGY (2009)
Hematopoietic Stem Cell Gene Therapy with a Lentiviral Vector in X-Linked Adrenoleukodystrophy
Nathalie Cartier et al.
SCIENCE (2009)
Complete correction of enzymatic deficiency and neurochemistry in the GM1-gangliosidosis mouse brain by neonatal adeno-associated virus-mediated gene delivery
M. L. D. Broekman et al.
MOLECULAR THERAPY (2007)
分享论文
